Genital Warts (Condylomata Acuminata) — Treatment

Key principle: No single treatment is superior to all others. Selection depends on wart size, number, anatomic site, patient preference, cost, and provider experience. (Harrison's Principles of Internal Medicine 22E, p. 1574; CDC STI Treatment Guidelines)

Treatment Overview

Patient-Applied Therapies

1. Imiquimod (3.75% or 5% cream)

• Mechanism: Immune response modifier — stimulates local cytokine production (IFN-α, TNF-α, IL-12).
• Regimen: 5% cream applied 3×/week at bedtime for up to 16 weeks; 3.75% applied nightly for up to 8 weeks. Wash off after 6–10 hours.
• Efficacy: Good for external genital warts; clearance rates ~50–80% for the 5% formulation.
• Side effects: Local erythema, erosion, itching, burning — frequent but usually mild to moderate.
• Notes: May weaken latex condoms and diaphragms. Self-administered; suitable for keratinized skin.

2. Podofilox (Podophyllotoxin) 0.5% solution or gel

• Mechanism: Antimitotic — inhibits microtubule polymerization, causing wart necrosis.
• Regimen: Apply twice daily for 3 days, then 4 days off; repeat up to 4 cycles.
• Limits: Total area ≤10 cm²; volume ≤0.5 mL/day.
• Side effects: Mild to moderate local irritation, pain.
• Contraindications: Mucous membranes, pregnancy.

3. Sinecatechins (Veregen) 15% ointment

• Mechanism: Green tea extract with antiviral and antioxidant properties.
• Regimen: Applied 3×/day for up to 16 weeks.
• Side effects: Local skin reactions common; may weaken condoms.
• Notes: Not for immunocompromised patients or those with herpes genitalis.

Provider-Administered Therapies

4. Cryotherapy with Liquid Nitrogen

• Mechanism: Cytodestruction via freeze-thaw cycles.
• Efficacy: Good; cryotherapy is recommended as the safest, least expensive, and most effective first-line modality for penile and vulvar warts (Harrison's).
• Recurrence: Frequent across all modalities.
• Side effects: Mild — local pain, blistering; well tolerated.
• Repeat: Every 1–2 weeks as needed.

5. Trichloroacetic Acid (TCA) / Bichloroacetic Acid (BCA) 80–90%

• Mechanism: Chemical coagulation of proteins.
• Application: Apply small amount directly to warts only; allow to dry (forms white frosting). Sodium bicarbonate can neutralize excess. Repeat weekly as needed.
• Best for: Small, few warts on moist surfaces (vaginal, anal, oral mucosa).
• Side effects: Local burning, pain.

6. Surgical Removal

• Methods include tangential scissor excision, shave excision, curettage, electrosurgery.
• Efficacy: Excellent — immediate clearance.
• Best for: Large, bulky, or extensive warts; warts not responding to other treatments; or when rapid clearance is needed.
• Requires: Local anesthesia; may scar.

7. CO₂ Laser

• Efficacy: Excellent (60–90% clearance), with low recurrence (5–10%).
• Best for: Large or extensive warts; intraurethral warts; recalcitrant disease.
• Complications: Local pain, swelling, vaginal discharge.
• Drawback: Expensive, limited availability.

Treatment Comparison Table

Special Anatomical Considerations

Alternative/Adjunct Therapies

• Intralesional Candida antigen: Up to 80% cure rate; useful for recalcitrant warts; may cause flu-like cytokine-mediated side effects.
• Intralesional interferon: Effective but expensive, poorly tolerated.
• Photodynamic therapy (PDT): Limited data; alternative option.
• Bleomycin intralesional: Reserved for recalcitrant warts in adults; high efficacy but requires local anesthesia.
• Podophyllin resin 10–25%: No longer a recommended regimen due to availability of safer options and risk of systemic toxicity.

Key Clinical Points

• All treatments have high recurrence rates — patients should be counseled accordingly.
• No HPV-specific cure exists; spontaneous regression occurs in ~30% within 6 months.
• Combination therapy (e.g., provider cryotherapy + patient-applied imiquimod between visits) is sometimes used but has limited supporting data.
• Malignant transformation: Warts from HPV-6/11 are low-risk, but concurrent high-risk HPV types (16, 18, 31, 33) can co-exist and cause HSIL. Atypical, pigmented, or non-responsive lesions warrant biopsy.
• Immunocompromised patients (HIV, transplant recipients) have more extensive, recalcitrant disease — combination/escalation therapy often required.
• Sexual partners should be examined; current sex partners may already be infected. Condoms reduce (but do not eliminate) transmission risk.

Prevention — HPV Vaccination

• Gardasil 9 (9vHPV) targets HPV 6, 11, 16, 18, 31, 33, 45, 52, 58 — highly effective at preventing anogenital warts and cervical/anogenital cancers.
• Recommended through age 26; shared decision-making for ages 27–45.
• Not therapeutic — does not clear existing infection or treat current warts.